1. Dispensing Medicines


Updated 19/02/2021


Branded products requests in the dosage section of prescriptions

Image of part of a prescription

Occasionally, a GP, nurse or pharmacist may prescribe an item using the generic name on a prescription, but request that a particular brand be supplied through instructions written in the dosage section of a prescription.

The NHSBSA have stated that only the information captured on the ‘drug line’ of an electronic prescription will be read by  and therefore the pharmacy will only be reimbursed (and the prescribing practice charged) for the generic or Drug Tariff price of the item as prescribed, rather than the branded or proprietary product which may be considerably more expensive.

Where this is the case, you should discuss this with the prescriber in the first instance, requesting that the prescription is amended to the appropriate brand. If the prescriber is unwilling to change, it will then be for the contractor to decide whether to supply the generic medicine as prescribed, or the brand requested.

Community Pharmacy Lincolnshire does not condone ‘hidden brand’ prescribing and are working with the CCG and LMC to reduce this issue. So that we can assess the scale of the issue, if you experience this please complete the form below (this will take no more than five minutes).

Back to top


Dispensing unlicensed specials or imports

In May 2020 the Department of Health and Social Care (DHSC) made some adjustments to the Drug Tariff to incorporate new arrangements in light of the COVID-19 pandemic response.

As a result, pharmacies are no longer required to submit copies of the Certificate of Conformity (COC) or Certificate of Analysis (COA) to the NHS England & Improvement team of the prescriber after dispensing unlicensed specials or imports not listed in Part VIIIB of the Drug Tariff (the ‘Specials Tariff’).

You are still required to keep the necessary records of unlicensed specials or imports you dispense, and retain any COCs and COAs obtained  for a period of five years.

Back to top


Stock shortages and Serious Shortage Protocols

Shortages of medicines are becoming an increasingly frequent issue that can hinder pharmacy teams’ efforts to dispense medicines in a timely manner, havng an impact on both pharmacy teams’ workload and on patients.

We’ve produced some simple guidance to support pharmacy teams to manage stock shortages, and will update this guidance as processes change.

You can find more detailed information, including how to report medicines shortages or pricing issues (for example where stock cannot be obtained at the Drug Tarrif price) on the PSNC Medicines Shortages webpage:

Serious Shortage Protocols

One mechanism for managing established medicines shortages are Serious Shortage Protocols. These are issued by the government and allow pharmacists to provide patients with an alternative product or quantity to their original prescribed treatment without the need to refer back to the prescriber. You can find more information on these using the link below:

Where these are in place for specified medicines, patients should not be referred back to their GP practice unless the alternatives are not acceptable to the patient. Information on the current SSPs can be found at:

Please check these links before referring patients back to their GP for the prescribing of alternatives to ensure that an SSP is not in place.

Back to top